Mast-Cell Stabilizing Effects of Olopatadine

Clinical trial NCT00389025 · COMPLETED

Trial details

NCT number: NCT00389025
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Allergic Conjunctivitis

Start date: 2006-10-01
Primary completion: 2007-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.